BioTech Stock Report Company Profile

23:28 EDT 24th March 2018 | BioPortfolio

Each month the Wong's BioTech Stock Report provides a fresh, intuitive, inside look at the science and business of biotech investing. Our report takes you behind the canned quotes from press releases, beyond the momentum-driven stock analysts, and past the hype of mainstream stock-touters. The BioTech Stock Report gets to the core of what makes biotechnology companies tick: Science and Innovation.
The Wong's BioTech Stock Report is the only biotech newsletter that explains recent developments in light of underlying technology. The BioTech Stock Report looks beyond short-term successes and setbacks because we know that in the long run good technology wins the biotech game.


P.O. Box 7274
United States of America


Phone: (503) 649-1355
Fax: (503) 649-4490

News Articles [2765 Associated News Articles listed on BioPortfolio]

Insider Buying: Fortress Biotech, Inc. (FBIO) CEO Buys 40,000 Shares of Stock

Fortress Biotech, Inc. CEO Lindsay A. Md Rosenwald acquired 40,000 shares of the stock in a transaction dated Monday, November 6th. The stock was bought at an average price of $25.00 per share, with a...

Exciting Biotech Stock Now Breaking Out of Large Base

March 6, 2018 ( Newswire) Technical analyst Clive Maund takes a look at a biotech stock that he views as a strong buy.

Fortress Biotech nets $23.25mm in preferred stock offering

Fortress Biotech Inc. netted $23.25mm in a stock offering of 1mm shares of Series A preferred stock at $25 per share. The preferred stock pays an annual dividend of 9.375% payable quarterly. The com...

Why This Maryland Biotech Could Double Its Stock by 2018

This biotech has had a year where its stock had grown 20 percent and roller-coastered down 20 percent, several times.

#news #biotech CRISPR CSO departs as Celgene continues to sell stock

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CRISPR CSO departs as Celgene continues to sell stock .Bill Lundberg, M.D., h...

Biotech Stock Performance Review - Vanda Pharma, Verastem, Acceleron Pharma, and Zai Lab

If you want a Stock Review on VNDA, VSTM, XLRN, or ZLAB then come over to sign up for your free customized report. Read more...

Brokerages Set Fortress Biotech Inc (FBIO) Price Target at $11.00

Fortress Biotech Inc has been given an average rating of "Hold" by the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock...

Fortress Biotech, Inc. (FBIO) CEO Acquires $1,000,000.00 in Stock

Fortress Biotech, Inc. CEO Lindsay A. Md Rosenwald purchased 40,000 shares of the business's stock in a transaction dated Monday, November 6th. The shares were purchased at an average cost of $25....

PubMed Articles [647 Associated PubMed Articles listed on BioPortfolio]

Just how good an investment is the biopharmaceutical sector?

Uncertainty surrounding the risk and reward of investments in biopharmaceutical companies poses a challenge to those interested in funding such enterprises. Using data on publicly traded stocks, we tr...

Biotech Crop Planting Resumes High Adoption in 2016.

The global area of biotech crops in 2016 increased from 179.7 million hectares to 185.1 million hectares, a 3% increase equivalent to 5.4 million hectares. Some 26 countries planted biotech crops, 19 ...

First Assessment of Carbon Stock in the Belowground Biomass of Brazilian Mangroves.

Studies on belowground roots biomass have increasingly reported the importance of the contribution of this compartment in carbon stock maintenance in mangrove forests. To date, there are no estimates ...

Interproximal Papilla Stability Around CAD/CAM and Stock Abutments in Anterior Regions: A 2-Year Prospective Multicenter Cohort Study.

The aim of this study was to compare the interproximal papilla stability of restorations supported by computer-aided design/computer-assisted manufacture (CAD/CAM) abutments to those supported by pref...

Carbon stock of Moso bamboo (Phyllostachys pubescens) forests along a latitude gradient in the subtropical region of China.

Latitude is an important factor that influences the carbon stock of Moso bamboo (Phyllostachys pubescens) forests. Accurate estimation of the carbon stock of Moso bamboo forest can contribute to suffi...

Clinical Trials [882 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies

This is a phase I, randomized, double blind, placebo-controlled safety, illness, and infection study of a new experimental human challenge stock of the Norovirus genogroup II, genotype 2 (...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

A Trial of an Audit and Feedback Report to Improve Colonoscopy Performance

This project aims to measure the impact of a physician report card (also called an audit & feedback report) on colonoscopy performance. Endoscopists in Ontario will be randomly assigned to...

Analysis of the Osteogenic Potential of Multipotent Cells From Different Anatomical Regions

The aim of hip replacement surgery is to re-establish the physiological hip function and to obtain a stable fixation between the prosthetic components and the native bone. Commonly, the fi...

Companies [1574 Associated Companies listed on BioPortfolio]

BioTech Stock Report

Each month the Wong's BioTech Stock Report provides a fresh, intuitive, inside look at the science and business of biotech investing. Our report takes you behind the canned quotes from press releases,...

Biotech Stock Letter

Biotech Stock Letter is an independent publisher focusing on the investment opportunities in the biotech sector and targeting undervalued biotechnology equities. Biotech Stock Letter is an email newsl...

Biotech Sage

BioTech Sage Report is newsletter that is published monthly. Our report provides quality investment research and information for uncovering the best ideas in stocks and investment strategies. While ou...

BIOTECH Patent News

BIOTECH Patent News is a monthly printed publication that keeps you updated on the latest events in the world of patented biotechnology. This site provides updates on the latest headlines from BIOTECH...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

More Information about "BioTech Stock Report" on BioPortfolio

We have published hundreds of BioTech Stock Report news stories on BioPortfolio along with dozens of BioTech Stock Report Clinical Trials and PubMed Articles about BioTech Stock Report for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioTech Stock Report Companies in our database. You can also find out about relevant BioTech Stock Report Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record